Calmare Therapeutics Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 5/20/2016
Contact Info
  • 1375 Kings Highway East
  • Fairfield, CT 06824

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0000102198
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Business Status Development Stage Company a/o Oct 29, 2013
Incorporated In: DE, USA
Year of Inc. 1968
Employees 8 a/o May 20, 2016
Company Officers/Contacts
Conrad Mir CEO, President
Christine Chansky, M.D., J.D. Officer
Thomas Richtarich CFO
Stephen J. D'Amato, M.D. Chief Med. Officer
Carl O'Connell Advisor
Janet Vasquez Public Relations
Company Directors
Peter Brennan Chairman
Rustin Howard
Conrad Mir
Carl O'Connell
Robert Conway, Jr., USN Ret
Stephen Roerich, USN Ret.
Stan Yarbro
Company Notes
  • Formerly=Competitive Technologies, Inc. until 6-2015
  • Formerly=University Patents, Inc. until 12-94
Service Providers
Accounting/Auditing Firm
Mayer Hoffman McCann CPAs
The New York Practice of Mayer Hoffman McCann P.C.
1065 Avenue of the Americas
New York, NY, 10018
United States

Legal Counsel
Szaferman Lakind Blumstein & Blader, PC
101 Grovers Mill Road
2nd Floor
Lawrenceville, NJ, 08648
United States

Investor Relations Firm
JV Public Relations
99 Madison Avenue
Suite 5001
New york, NY, 10016
United States

CTTC Security Details
Share Structure
Market Value1 $4,433,326 a/o Oct 21, 2016
Authorized Shares 100,000,000 a/o May 20, 2016
Outstanding Shares 28,787,831 a/o May 19, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 21,204,486 a/o May 19, 2016
Par Value No Par Value
Shareholders of Record 443 a/o May 03, 2016
Short Selling Data
Short Interest 4,968 (0.51%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security